Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 241 | 2022 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 78 | 2022 |
Screening, diagnostic and prognostic tests for COVID-19: a comprehensive review M Ulinici, S Covantev, J Wingfield-Digby, A Beloukas, AG Mathioudakis, ... Life 11 (6), 561, 2021 | 30 | 2021 |
Basic life support providers’ assessment of centre of the chest and inter-nipple line for hand position and their underlying anatomical structures J Yeung, T Butler, JW Digby, J Hughes, D Higgie, M Minshall, B Miller, ... Resuscitation 82 (2), 190-194, 2011 | 27 | 2011 |
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 24 | 2023 |
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 12 | 2023 |
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 6 | 2024 |
Primary Ewing sarcoma of the lung: a challenging case HH Wu, J Wingfield-Digby, G Jifon Journal of the Royal College of Physicians of Edinburgh 50 (2), 141-143, 2020 | 6 | 2020 |
CPAP appears to protect kidney function of patients with OSA JW Digby, A Mathioudakis, R Heartshorne, M Mohammad, D Tewkesbury, ... European Respiratory Journal 50 (suppl 61), 2017 | 5 | 2017 |
Syncope: a complication of chronic cough J King, S Hennessey, JW Digby, JA Smith, P Marsden Breathe 17 (4), 2021 | 4 | 2021 |
The missing antibody: the pitfalls of ANCA testing JW Digby, B Tinwell, J Sheldon, J Wang The American Journal of Medicine 130 (3), e93, 2017 | 4 | 2017 |
Productive cough, a forgotten phenotype of refractory chronic cough J King, JW Digby, S Hennessey, P Marsden, J Smith Respiratory Medicine and Research 86, 101106, 2024 | 3 | 2024 |
Bronchoscopy for refractory/unexplained cough with mucus JW Digby, J King, B Al-Sheklly, P Marsden, S Fowler, J Smith Respiratory Medicine 217, 107335, 2023 | 3 | 2023 |
Real world effectiveness and tolerability of low-dose opiates for refractory/unexplained chronic cough (RCC/UCC) in a tertiary clinic J King, J Wingfield-Digby, S Hennessey, A Woodcock, J Smith, P Marsden, ... European Respiratory Journal 60 (suppl 66), 2022 | 3 | 2022 |
Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted? M Fally, AG Mathioudakis, JW Digby, PR Williamson Clinical Microbiology and Infection 28 (3), 456-457, 2022 | 3 | 2022 |
S18 Describing the triggers and sensations associated with coughing across different disease groups S Galgani, L Boone, J Wingfield-Digby, J King, R Dockry, J York, H Badri, ... Thorax 77 (Suppl 1), A15-A15, 2022 | 2 | 2022 |
Hypotonic saline effectively discriminates refractory/unexplained chronic cough from healthy volunteers JW Digby, J King, R Dockry, S Sen, S Galgani, P Marsden, J Smith European Respiratory Journal 60 (suppl 66), 2022 | 2 | 2022 |
Systematic review of the effectiveness of non-pharmacological interventions used to treat adults with inducible laryngeal obstruction J Haines, JA Smith, J Wingfield-Digby, J King, J Yorke, SJ Fowler BMJ Open Respiratory Research 9 (1), e001199, 2022 | 2 | 2022 |
Refractory chronic cough patients are indiscriminately hyper-responsive to inhaled tussive irritants/agents J King, B Al-Sheklly, J Wingfield Digby, S Sen, J Mitchell, PA Marsden, ... B40. ASSESSMENT AND TREATMENT OF COUGH AND DYSPNEA, A2809-A2809, 2022 | 2 | 2022 |
Is there clinical value in performing capsaicin cough challenges in patients with severe asthma? J King, JW Digby, I Satia Breathe 17 (2), 2021 | 2 | 2021 |